08045804946
medisus.pharma007@gmail.com
Change Language
Efavirenz Tablets

Efavirenz Tablets

1300 INR/Bottle

Product Details:

  • Dosage Form Tablet
  • Salt Composition Efavirenz
  • Indication Treatment of HIV-1 infection as part of antiretroviral combination therapy
  • Enzyme Types Non-nucleoside reverse transcriptase inhibitor (NNRTI)
  • Feature High bioavailability, convenient once-daily dosing
  • Ingredients Efavirenz, Excipients
  • Application Antiviral medication
  • Click to View more
X

Efavirenz Tablets Price And Quantity

  • 5 Bottle
  • 1300 INR/Bottle

Efavirenz Tablets Product Specifications

  • Store below 30C, protect from moisture
  • Efavirenz, Excipients
  • Inhibits HIV-1 reverse transcriptase enzyme
  • Odorless
  • Efavirenz
  • Treatment of HIV-1 infection as part of antiretroviral combination therapy
  • Tablet
  • White film-coated tablet
  • High bioavailability, convenient once-daily dosing
  • Non-nucleoside reverse transcriptase inhibitor (NNRTI)
  • 24 to 36 months
  • Antiviral medication

Efavirenz Tablets Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 1000 Bottle Per Week
  • 4 Days
  • All India, South India, Central India, West India, North India, East India, Gujarat, Karnataka, Kerala, Lakshadweep, Mizoram, Meghalaya, Manipur, Andhra Pradesh, Bihar, Chandigarh, Daman and Diu, Goa, Jharkhand, Odisha, Punjab, Assam, Delhi, Dadra and Nagar Haveli, Andaman and Nicobar Islands, Arunachal Pradesh, Chhattisgarh, Haryana, Himachal Pradesh, Jammu and Kashmir, Madhya Pradesh, Maharashtra, Nagaland, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, Pondicherry, Uttar Pradesh, Uttarakhand, West Bengal

Product Description

Efavirenz tablets IP 600 mg contain the active ingredient efavirenz, which is an antiretroviral medication used in the treatment of HIV infection. Efavirenz belongs to the class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs).


Here's how efavirenz works:


1. Inhibition of Reverse Transcriptase HIV is a retrovirus that relies on an enzyme called reverse transcriptase to convert its RNA genome into DNA, which is then integrated into the host cell's DNA. Efavirenz inhibits the action of reverse transcriptase, preventing the virus from replicating and reducing the viral load in the body.


2. Blocking HIV Replication By inhibiting reverse transcriptase, efavirenz helps to suppress HIV replication. This slows down the progression of HIV infection, reduces the risk of opportunistic infections, and preserves immune function.


Efavirenz is typically used in combination with other antiretroviral drugs as part of a comprehensive HIV treatment regimen known as antiretroviral therapy (ART). This combination therapy is tailored to the individual patient based on factors such as their viral load, CD4 cell count, treatment history, and any drug resistance mutations present.


It's essential for patients taking efavirenz tablets to follow their healthcare provider's instructions carefully and to take the medication exactly as prescribed. Skipping doses or not taking the medication consistently can lead to treatment failure and the development of drug-resistant strains of HIV.


Common side effects of efavirenz may include dizziness, drowsiness, trouble sleeping, vivid dreams, and rash. Some individuals may experience more severe side effects, so it's important to report any unusual or severe symptoms to a healthcare provider promptly.


As with any medication, efavirenz tablets can interact with other drugs, so it's important for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting efavirenz therapy.


Overall, efavirenz is an important component of HIV treatment and has been shown to be effective in helping people with HIV manage their condition and improve their quality of life.



How Efavirenz Tablets Combat HIV

Efavirenz Tablets work by targeting and inhibiting the HIV-1 reverse transcriptase enzyme, an essential component in the virus's replication process. As part of a combination antiretroviral therapy, Efavirenz helps to effectively lower the viral load in the bloodstream, supporting immune function and slowing the progression of HIV-1 infection.


Benefit of Once-Daily Dosing

With high bioavailability and a convenient once-daily regimen, Efavirenz Tablets offer improved patient compliance and ease of use. This streamlined dosing schedule helps individuals maintain their treatment routine, contributing positively to overall health outcomes for both adults and eligible children.


Proper Storage and Shelf Life

Efavirenz Tablets should be stored below 30C and protected from moisture to maintain their efficacy. Packaged in either blister or bottle packs, they boast a generous shelf life of 24 to 36 months, making them reliable for healthcare providers, suppliers, and patients alike.

FAQ's of Efavirenz Tablets:


Q: How should I take Efavirenz Tablets for the treatment of HIV-1 infection?

A: Efavirenz Tablets are administered orally, typically once daily, as part of a combination antiretroviral therapy. It is important to follow your healthcare provider's instructions and take the tablets at the same time each day for best results.

Q: What are the available strengths and packing types for Efavirenz Tablets?

A: Efavirenz Tablets are offered in 600 mg and 200 mg strengths. They are packaged in both blister packs and bottle packs to suit different needs and preferences.

Q: When should Efavirenz Tablets not be used?

A: Efavirenz Tablets should not be used in individuals with a known allergy to Efavirenz or any of the tablet excipients. Always consult your healthcare provider if you have concerns regarding contraindications.

Q: What are the possible side effects associated with Efavirenz Tablets?

A: Possible side effects include rash, dizziness, insomnia, and abnormal dreams. In most cases, these symptoms are mild, but you should consult your doctor if they persist or worsen.

Q: Can Efavirenz Tablets be co-administered with other HIV medications?

A: Yes, Efavirenz Tablets are designed to be co-administered with other antiretroviral agents as part of a combination therapy. This combination enhances the effectiveness of HIV-1 treatment.

Q: Where are Efavirenz Tablets manufactured, and what regulatory approvals do they have?

A: Efavirenz Tablets are manufactured in India in accordance with regulatory approvals from WHO, USFDA, and EMEA guidelines, ensuring their safety and efficacy for global distribution.

Q: What are the recommended storage instructions for Efavirenz Tablets?

A: Efavirenz Tablets should be stored below 30C and protected from moisture to preserve their quality throughout their 24 to 36-month shelf life.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'HIV Medicines' category



Back to top